DATA 2000 Waivers The Drug Addiction Treatment Act of 2000 (DATA 2000) permits physicians who meet certain qualifications to treat opioid dependency with.

Slides:



Advertisements
Similar presentations
Aug 7 09 Co-Occurring Service Array Psychiatric Evaluation Comprehensive Evaluation Medication Monitoring Medications Clinical Consultation Family Therapy.
Advertisements

Pharmacy Services Agreements Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 5/08/06.
Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
The Physician-PA Team Improving Access to Patient Care.
Disease State Management The Pharmacist’s Role
VIRGINIA PRESCRIPTION MONITORING PROGRAM C.A.R.E Presentation February 27, 2015 Ralph Orr Director, Virginia Prescription Monitoring Program.
Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.
Martin Duke, MD, MRO February 20, Introduction Who can be a Medical Examiner? Medical Examiner Training and Certification Medical Examiner Requirements.
2 H. Westley Clark, M.D., J.D., M.P.H., CAS, FASAM Director Center for Substance Abuse Treatment Substance Abuse Mental Health Services Administration.
Indiana Community Health Centers from the State Perspective A Presentation to Indiana Council of Community Mental Health Centers.
Medical Law and Ethics Lesson 3: Documentation and Regulations.
Chapter 1. OBJECTIVES  see p-2 of text book KEY TERMS / CONCEPTS  controlled substances  Drug Enforcement Administration (DEA)  drug standards  Food.
What’s New at FCB: Update on Certification & Resources Pamela Waters, MEd, CAP, CPP Director of Operations, FCB LaTonya Randolph Certification Specialist.
Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
April 15 th is not just the deadline for your taxes!!! Is your documentation complete for Pharmacist to Registered Technician Ratios? Policies.
SCOPE OF PRACTICE: NURSING IN OHIO Pamela S. Dickerson, PhD, RN-BC, FAAN
Career Project By: Tiffany Miller. Description: Provide healthcare services typically performed by a physician, under the supervision of a physician,
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Department of Health and Vanderbilt University Chronic Pain Guidelines Symposium Elizabeth Lund, Executive Director, Board of Nursing Linda Johnson, APN.
Baltimore Buprenorphine Initiative Advancing Recovery Project Baltimore City, Maryland January 14, 2010.
William Hovland, MD, CMD Marc Nevin, MD, CMD Angel Rivera, BSHA.
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
1 The Health Team HST 2 2 Introduction Care of the sick, the prevention of illness and the promotion of health and general welfare requires a combination.
Ensuring Availability and Preventing Diversion International Pain Policy Fellowship August 7, 2012 David E. Joranson University of Wisconsin Pain & Policy.
WESTCARE NEVADA Community Triage Center WestCare Nevada has been providing social model, non medical detoxification services to the community since 1989.
Drug Regulations & Control
LECTURE FOR ASSIGNMENT 1 AND 2
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
Table of Contents.  Legal and Safety Issues Go Go  Prescriptions and Abbreviations Go Go.
دکترارتین کمالی ثابتی ( متخصص پزشکی قانونی ومسمومیتها )
Introduction to Suboxone What Family Physicians Can Offer Friday April 15th, 2016 John L Bender, MD, MBA,FAAFP.
Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Sources: National Journal Research 2016, Jordain Carney, “Senate passes opioid abuse bill,” The Hill, March 10, 2016; Nadia Kounang, “Obama Announces New.
ABC-MAP Act 191 of 2014 September 16, 2016 Pennsylvania’s Prescription Drug Monitoring Program (PA PDMP)
Mary Lou Leary Deputy Director for State, Local, and Tribal Affairs Office of National Drug Control Policy A Drug Policy for the 21 st Century A Drug Policy.
Physician assistants and Advanced practice Nurses who are they?
Master’s Level Addiction Professional
Medication Assisted Treatment
Medication Assisted Treatment for Substance Use Disorders and the
April 15th is not just the deadline for your taxes
Medication Assisted Treatment
Legal and Regulatory Issues in Pain Management
Medication-Assisted Therapy at Coleman Profession Services
Caldwell County Narcotic Initiative
Updates Regarding New Physician Assistant Rules
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
Susan y swart Ed.D, rn, cae Executive director Ana-Illinois
Telepractice Delivery of Services in OASAS Programs.
The Power of the PA Profession
Tri-Service Buprenorphine Training
Federal Regulations requirements for opioid prescription course
MENTAL HEALTH LEGISLATION
DATE : 19 June 2018 BY : Palesa Santho
Coordinating Federal Resources and Collaboration Amongst Grantees
Leveraging the Utilization of Telemedicine to Improve Access to Care
Issues on Dispensing Dr Percy Mahlathi.
National Credentialing Forum February 7, 2019
Illinois Prescription Monitoring Program
Addiction Treatment Program North Canyon Medical Center
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Vision Transformative collaboration that fosters resilient self-sustaining Recovery Communities. Mission To develop and sustain measurable solutions that.
A Training For Multidisciplinary Addiction Professionals
Community-Based Strategies for Preventing Opioid Abuse
Medication Assisted Treatment of Opioid Use Disorder
Transforming the Delivery of Substance Use Disorder Treatment in States Update August 2019.
Colorado Legislative Roundtable
Presentation transcript:

DATA 2000 Waivers The Drug Addiction Treatment Act of 2000 (DATA 2000) permits physicians who meet certain qualifications to treat opioid dependency with narcotic medications approved by the FDA – including buprenorphine – in treatment settings other than OTPs. Must receive waiver (known as “DATA Waiver”) to prescribe. “Qualifying physician” must be Licensed under state law Registered with DEA to dispense controlled substances Qualified by training/certification Addictions/addictions psychiatry certification OR Approved 8 hour training course Capable of referring patients to counseling and other services

Nurse Practitioners/Physician’s Assistants Comprehensive Addiction and Recovery Act (CARA): NP and PA can also receive waivers Must meet/maintain all state law requirements for prescribing and receive 24 hours of approved training Hard limit of 30 patients per prescriber Open question: Indiana requires collaborative arrangement with physician to review 5% of charts with a prescription. Does the collaborating physician also need waiver?

Patient Limits Default for waiver is 30 patients per prescriber Physicians can apply to increase to 100, then 275 Disclaimer: no opinion is offered as to the wisdom or practicality of this approach Increase requires one year at the lower limit, additional credentialing (certification in addiction medicine or addiction psychiatry) AND proof of a “Qualified Practice Setting” Increase is good for a three year period, must file to renew

“Qualified Practice Setting” Provides professional coverage for patient medical emergencies during hours when the practice is closed. Provides access to case management services for patients, including referral and follow-up services for programs that provide or financially support medical, behavioral, social, housing, employment, educational, or other related services. Uses health information technology if it is already required in the practice setting. Is registered for their state prescription drug monitoring program where operational and in accordance with federal and state law (INSPECT program) Accepts third-party payment for some services, though not necessarily for buprenorphine-related services and not necessarily all third-party payers Have adopted a “diversion control plan”

How to Apply /More information https://www.samhsa.gov/programs- campaigns/medication-assisted-treatment/training- materials-resources/buprenorphine-waiver